KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) FCF Margin (2016 - 2025)

Evolent Health (EVH) has 11 years of FCF Margin data on record, last reported at 215.88% in Q4 2025.

  • For Q4 2025, FCF Margin fell 21087.0% year-over-year to 215.88%; the TTM value through Dec 2025 reached 0.34%, up 58.0%, while the annual FY2025 figure was 8.27%, 803.0% down from the prior year.
  • FCF Margin reached 215.88% in Q4 2025 per EVH's latest filing, down from 1.43% in the prior quarter.
  • Across five years, FCF Margin topped out at 26.84% in Q4 2021 and bottomed at 215.88% in Q4 2025.
  • Average FCF Margin over 5 years is 10.6%, with a median of 0.45% recorded in 2024.
  • Peak YoY movement for FCF Margin: skyrocketed 3372bps in 2021, then tumbled -21087bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 26.84% in 2021, then tumbled by -76bps to 6.52% in 2022, then skyrocketed by 130bps to 14.99% in 2023, then plummeted by -133bps to 5.01% in 2024, then crashed by -4210bps to 215.88% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 215.88% in Q4 2025, 1.43% in Q3 2025, and 8.8% in Q2 2025.